| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 07/02/2008 | CN100398648C Probe foranalysis of nucleic acids |
| 07/02/2008 | CN100398551C Novel isoforms of vascular endothelial cell growth inhibitor |
| 07/01/2008 | USH2220 oligonucleotide probes which can discriminate between alleles of nucleic acid in assays; linkage studies in families and disequilibrium in isolated populations |
| 07/01/2008 | US7393999 Antimicrobial peptides and methods of use |
| 07/01/2008 | US7393996 Tomatoes having reduced polygalacturonase activity caused by non-transgenic mutations in the polygalacturonase gene |
| 07/01/2008 | US7393951 antisense to a nucleotide sequence of positions 47 to 51 of 7SL RNA of the signal recognition particle (SRP); inhibitor of cancer cell growth |
| 07/01/2008 | US7393950 To inhibit the growth of tumor cells in mammals |
| 07/01/2008 | US7393948 increase in yield, disease resistance, insect resistance, herbicide tolerance, drought tolerance and salt tolerance in plants |
| 07/01/2008 | US7393945 Estrogen receptor genes and utilization thereof |
| 07/01/2008 | US7393944 Lymphocytes; transcription factors; interferons |
| 07/01/2008 | US7393943 for the treatment of leukemia, tumors, chronic infections, auto-immune disease, fibrotic disorders, wound healing and psoriasis |
| 07/01/2008 | US7393942 Nucleic acids encoding mutant forms of Fas ligand |
| 07/01/2008 | US7393941 screening assay to identify agents having antiviral activity against a DNA virus by assessing the effect of a candidate agent upon alternative splicing of MxA |
| 07/01/2008 | US7393940 relates to inherited variations in genes believed to be involved in base excision repair (BER) pathways of humans; screening patients for defects in BER and thereby for cancers or predisposition to cancers |
| 07/01/2008 | US7393939 Transport protein for use in the removal of the xenobiotics from mammals |
| 07/01/2008 | US7393931 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 07/01/2008 | US7393927 Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof |
| 07/01/2008 | US7393923 Red-shifted fluorescent proteins mPlum and mRaspberry and polynucleotides encoding the same |
| 07/01/2008 | US7393922 Insecticidal Cry4Ba proteins with enhanced toxicity |
| 07/01/2008 | US7393918 Protein binding miniature proteins and uses thereof |
| 07/01/2008 | US7393682 Polynucleotides encoding promyostatin polypeptides |
| 07/01/2008 | US7393679 Enzyme for degrading hyaluronic acid to amino acid; genetic engineered gene |
| 07/01/2008 | US7393675 Nucleotide sequences coding sugar metabolism and oxidative phosphorylation (SMP) protein for preparation and generation of amino acid for use in foods, cosmetics and medicines; bioremediation; terpenoid biosynthesis |
| 07/01/2008 | US7393671 Mutant carotenoid ketolases |
| 07/01/2008 | US7393669 Metabolically engineered micro-organisms having improved galactose uptake |
| 07/01/2008 | US7393660 Polypeptide of given sequence; transforming or transfecting cell with expression vector; inhibits tumor necrosis factor release; anti-inflammatory |
| 07/01/2008 | US7393654 Nucleotide sequences coding G-protein coupled receptor (T2R) for use in identifying modulators which control bitterness; food processing and pharmocological design |
| 07/01/2008 | US7393651 Confluence regulated adhesion molecules useful in modulating vascular permeability |
| 07/01/2008 | US7393648 Hybrid antibodies |
| 07/01/2008 | US7393647 Kit comprising affinity agent immobilized on microtiter plate, forms complex with labeled antibody; surface array proteins; diagnosing anthrax |
| 07/01/2008 | US7393646 Method, apparatus and system for quantifying the content of genetically modified material in a sample |
| 07/01/2008 | US7393645 Self-assembled with mixtures of conductive oligomers and insulators |
| 07/01/2008 | US7393644 Method for real-time detection of polymerase chain reaction |
| 07/01/2008 | US7393643 Method of detecting ivermectin sensitivity in a canine subject by identifying a mutation in a MDR1-encoding sequence |
| 07/01/2008 | US7393642 Using paired-like homeobox 2b (PHOX2b) gen sequences as diagnostic tools in diagnosis and prevention of respiratory system disorders |
| 07/01/2008 | US7393641 Using carcinoembryonic antigen sequence specific primer from tumor site to monitor tumor preferential gene expression in cells/tissues distant from site of tumor manifestation |
| 07/01/2008 | US7393636 Method for forming self-assembly substance using oligonucleotide synthesized by gene amplification reaction, self-assembly substance and method for detecting gene |
| 07/01/2008 | US7393634 Identifying individual as having increased risk of accelerated human immunodeficiency virus by detecting presence of haplotype pairs |
| 07/01/2008 | US7393318 Methods and compositions for interaction trap assays |
| 06/28/2008 | CA2612505A1 High throughput genome specific molecular markers for erucic acid content genes in brassica napus (l.) |
| 06/26/2008 | WO2008076377A2 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition |
| 06/26/2008 | WO2008051530A9 Polymerase enzymes and reagents for enhanced nucleic acid sequencing |
| 06/26/2008 | WO2008039357A9 Uncoupling of dna insert propagation and expression of protein for phage display |
| 06/26/2008 | WO2008005828A3 PHARMACEUTICALLY ACCEPTABLE COMPOSITIONS COMPRISING ANTIBODY MOLECULES SPECIFIC TO LAMININ-5 α3 CHAIN DOMAINS G1G2 AND USE THEREOF |
| 06/26/2008 | WO2007143317A3 Compounds and methods for modulating expression of crp |
| 06/26/2008 | WO2007143316A3 Compounds and methods for modulating expression of sglt2 |
| 06/26/2008 | WO2007117686A3 Stabilized immune modulatory rna (simra) compounds for tlr7 and tlr8 |
| 06/26/2008 | WO2007070488A3 Integrin alpha l i domain mutants with increased binding affinity |
| 06/26/2008 | WO2007035922A3 Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics |
| 06/26/2008 | WO2006127514A3 Compositions and methods for treating hiv infection with cupredoxin and cytochrome c |
| 06/26/2008 | WO2005120230A3 POSITIONALLY MODIFIED siRNA CONSTRUCTS |
| 06/26/2008 | WO2005115410A3 Context dependent inhibitors of cytidine deaminases and uses thereof |
| 06/26/2008 | US20080155717 Polycomb genes from maize - mez1 and mez2 |
| 06/26/2008 | US20080155716 Serine hydroxymethyltransferase as target for herbicides |
| 06/26/2008 | US20080155715 Stress-Responsive Root-Specific Genes |
| 06/26/2008 | US20080155714 oil producing crop plant is produced by transfecting; efficient production of cyclopropane fatty acids in an oilseed crop; forming biodegradable lubricants from plant oil; intermediates to branched fatty acids with the low temperature properties and resist to oxidation |
| 06/26/2008 | US20080155713 Lipid Metabolic and Signalling Pathways in the Epidermis |
| 06/26/2008 | US20080155712 Means for identifying nucleotide sequences involved in apomixis |
| 06/26/2008 | US20080154029 Process For Manufacturing a Composite Sorbent Material For Chromatographical Separation of Biopolymers |
| 06/26/2008 | US20080154028 Novel calcium-independent phospholipases A2, genes thereof and promoter of the same |
| 06/26/2008 | US20080154027 nucleotide sequences comprising a Yarrowia genetic translation initiation site, for encoding desaturases |
| 06/26/2008 | US20080153772 Oligonucleotides For Rna Interference and Biological Applications Thereof |
| 06/26/2008 | US20080153769 A nucleic acid ligand whose sequence optionally includes a 2'-O-methyl modification and/or a 2'-O-fluoro modification, useful for inhibiting coagulation in a host undergoing a therapeutic regime such as surgery or coronary artery bypass |
| 06/26/2008 | US20080153767 Modulation of forkhead box o1a expression |
| 06/26/2008 | US20080153766 Non-insulin dependent diabetes mellitus; lowers hepatic fatty degeneration; improving liver function by reducing alanine transaminase and aspartate transaminase levels |
| 06/26/2008 | US20080153765 Inducing apoptosis in a bcl-6-expressing cell or a non-Hodgkin's lymphoma cell; nucleic acid molecule having a sequence corresponding to or complementary to accessible regions of bcl-6 mRNA, vectors, cells, |
| 06/26/2008 | US20080153764 Used in cells and transgenic animals for a variety of applications including producing and studying the effects of RNAi and microRNA mediated gene silencing. |
| 06/26/2008 | US20080153763 Contains only promoter and transcription sequence regions which minimizes immunogenicity because it does not contain extra sequences; resistant to digestion and relatively stable in serum and cells |
| 06/26/2008 | US20080153756 Nucleic acids encoding them; for use in modulating alpha 4 integrin function; kits; antibodies against the peptides |
| 06/26/2008 | US20080153751 Albumin Fusion Proteins |
| 06/26/2008 | US20080153745 Compositions of tRNA and uses thereof |
| 06/26/2008 | US20080153161 Genetically Encoded Photosensitizers and Methods for Using Same |
| 06/26/2008 | US20080153159 Therapeutic and diagnostic agents |
| 06/26/2008 | US20080153156 Use of specific Factor IX polynucleotide coding sequence designed for optimal expression and use of transcriptional regulatory regions minimized in size so they can be used to express Factor IX, and other genes, in size-constrained environment such as in self complementary gene therapy vector; hemophilia |
| 06/26/2008 | US20080153141 nucleotide sequence encoding a polypeptide Delta 9 desaturase enzyme which has the ability to convert palmitic acid or stearic acid into palmitoleic acid or oleic acid respectively |
| 06/26/2008 | US20080153131 Free of transmembrane domain; immunoglobulins; autoimmune diseases |
| 06/26/2008 | US20080153130 Ubp1 Protease Mutant and Its Coding Sequence, Their Applications and Heterogonous Protein Expression System |
| 06/26/2008 | US20080153126 Mutant Aox1 Promoters |
| 06/26/2008 | US20080153112 identification of a predominant ligand of CD8+ T cells that are responsible eq for type 1 diabetes. That ligand is islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP). Several CD8+ T cell-binding peptides from IGRP are identified, including the peptide comprising amino acids |
| 06/26/2008 | US20080153107 Isolated PGE synthase, provided from encoding nucleic acid. Methods of production and use. Assays for modulators, especially inhibitors, of PGE synthase activity. |
| 06/26/2008 | US20080153106 Three human endometrial antigens, ME-5, ME-2 and EPP2, and combination thereof have been discovered that are the targets of antibodies present in the serum of women suffering from endometriosis. are used as tools for diagnostic assays these protein products and the human antibodies reactive with them |
| 06/26/2008 | US20080153095 Triphosphates having gamma-phosphate with a detectable group attached; detection using charge coupled device camera or photodiode |
| 06/26/2008 | US20080153094 Reduction of nonspecific binding in nucleic acid assays and nucleic acid synthesis reactions |
| 06/26/2008 | US20080153088 Cystic fibrosis transmembrane conductance regulator gene mutations |
| 06/26/2008 | US20080153086 Hybridizing cDNA from normal tissue to cDNA from an abnormal or test tissue; cDNA populations are separately tagged prior to hybridization, which allows isolation of double-stranded cDNA containing both normal and alternatively spliced molecules |
| 06/26/2008 | US20080153082 Improved stability in high salt concentration solutions, buffers; biosensors; non-nucleotide polyphosphate polymer with a recognition probe conjugated thereto; e.g. polyanion-gold nanoparticle conjugates |
| 06/26/2008 | US20080152673 Comprising histone protein and sugar in form of amorphous solid; plant seed extract effects drying tolerance |
| 06/26/2008 | US20080152662 At least two oligonucleotides linked at their 3' ends, internucleoside linkages or functionalized nucleobase or sugar to a nonnucleotidic linker, at least one oligonucleotide an immunostimulant having accessible 5' end |
| 06/26/2008 | US20080152649 Insulin-like growth factor 1 (IGF-1) receptor specific immunogloblin for use in diagnosis, prevention and treatment of cell proliferative |
| 06/26/2008 | US20080152645 Genetically Encoded Multifunctional Compositions Bidrectionally Transported Between Peripheral Blood and the CNS |
| 06/26/2008 | US20080152642 Aiolos, Helios, Daedalos and Ikaros: genes, polypeptides, regulatory elements and uses thereof |
| 06/26/2008 | US20080152633 Flavivirus Replicon Constructs for Tumor Therapy |
| 06/26/2008 | US20080152631 Cancer Antigen Peptides Derived from Wt1 |
| 06/26/2008 | US20080152620 Hemopoietic cytokine for use in diagnosis, prevention and treatment of skin and respiratory disorders |
| 06/26/2008 | US20080152587 TARGETED BINDING AGENTS DIRECTED TO uPAR AND USES THEREOF |
| 06/26/2008 | CA2675245A1 Use of lecithin:retinol acyl transferase gene promoter methylation in evaluating the cancer state of a subject |
| 06/25/2008 | EP1935992A2 Multiplexed nucleic acid analysis with high specificity for human papilloma virus |
| 06/25/2008 | EP1935991A2 Nucleic acid vaccines for prevention of flavivirus infection |
| 06/25/2008 | EP1934613A2 Sequences for detection and identification of methicillin-resistant staphylococcus aureus (mrsa) of mrej types xi to xx |
| 06/25/2008 | EP1934606A2 Optimized trpm8 nucleic acid sequences and their use in cell based assays and test kits to identify trpm8 modulators |